Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Qiagen Inc
    Registered Vendor
    • Dec 2015
    • 3

    #1

    Sequencing Development Lead, NGS Technologies

    The Sequencing Lead will be responsible for the development of sequencing chemistry related aspects of a QIAGEN next generation sequencing workflow. In this role the Sequencing Lead will lead a team of scientists and technical staff in a matrix role and be responsible to deliver all technical performance aspects of the sequencing process. Proactive interaction across different groups and departments is expected. We are looking for a skilled and motivated Lead with experience in managing a team and next-generation sequencing technologies.


    The Sequencing Lead will:


    Direct the development of all aspects of the sequencing segment of the NGS workflow, including chemistry, disposables, cooperate with hardware and software

    Ensure that all development activities within this area are compliant with QIAGEN global product development procedures

    Supervise the activities of a team of scientists and technical staff in a matrix management role

    Deliver the required technical performance of the sequencing process according to specification, on time and within budget

    Work collaboratively with other groups and departments (e.g. Operations department, Project Management) within the project to contribute to the successful development of the NGS workflow, from sample to insight

    Mentor and develop staff under their direction (in matrix role)

    Oversee experimental analysis to facilitate troubleshooting and development decision

    Experience with product development under design control is preferred

    Represent QIAGEN at scientific conferences and other outward facing events

    REQUIREMENTS

    PhD in Chemistry, Biochemistry, Molecular Biology or related fields

    Preferably 7+ years of relevant industry experience

    Excellent understanding of the underlying technical principles of next generation sequencing chemistries and workflows, associated instrumentation platforms and data analysis and interpretation algorithms

    Mandatory experience in next generation sequencing (NGS) technology and product development with a documented record of success in the life sciences and/or molecular diagnostics space

    Strong management skills with a track record of increasing responsibilities and the management of groups in a matrix; international experience preferred

    Very good troubleshooting, problem solving and organizational skills

    Proven leadership and successful decision-making qualities

    Strong technical writing and presentation skills

    Strong intellectual property protection skills and patent record

    Moderate travel required (up to 20%)

    To apply, please follow the link below:



    Qiagen is an Equal Opportunity Employer and do not discriminate against any employee or applicant for employment because of race, color, sex, age, national origin, religion, sexual orientation, gender identity, status as a veteran, and basis of disability or any other federal, state or local protected class.
    Last edited by Qiagen Inc; 12-08-2015, 12:47 PM.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...